ITIH5 has previously been shown to be epigenetically silenced in various cancer entities [17,18,19], including bladder cancer [20], where its expression was associated with tumor recurrence of the clinical important group of high-grade pT1 patients. Here, ITIH5 is linked to urinary bladder carcinoma.